Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application

NCT ID: NCT03780374

Last Updated: 2019-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-12-03

Study Completion Date

2019-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A methodical evaluation of novel sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired. These sound changing principles are enabled by respective hearing instrument algorithms. The aim of the study is to investigate and asses strength and weaknesses of these novel sound changing principles in terms of hearing performance to determine their application in hearing instruments (Phase of development). Both, objective laboratory measurements as well as subjective evaluations in real life environment will be carried out. This will be a controlled, single blinded and randomized active comparator clinical evaluation which will be conducted mono-centric at Sonova AG Headquarter based in Staefa.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Each participant will be treated with sound principle 1, 2 and 3 in a crossover design.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
The participant's will not know which intervention will be applied.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sound Processing Principle 1

Sound Processing Principle 1 will be applied in the hearing aid.

Group Type ACTIVE_COMPARATOR

Phonak Audéo L2M with Sound Processing Principle 1

Intervention Type DEVICE

Compensation of a hearing loss with Sound Processing Principle 1.

Sound Processing Principle 2

Sound Processing Principle 2 will be applied in the hearing aid.

Group Type EXPERIMENTAL

Phonak Audéo L2M with Sound Processing Principle 2

Intervention Type DEVICE

Compensation of a hearing loss with Sound Processing Principle 2.

Sound Processing Principle 3

Sound Processing Principle 3 will be applied in the hearing aid.

Group Type EXPERIMENTAL

Phonak Audéo L2M with Sound Processing Principle 3

Intervention Type DEVICE

Compensation of a hearing loss with Sound Processing Principle 3.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phonak Audéo L2M with Sound Processing Principle 1

Compensation of a hearing loss with Sound Processing Principle 1.

Intervention Type DEVICE

Phonak Audéo L2M with Sound Processing Principle 2

Compensation of a hearing loss with Sound Processing Principle 2.

Intervention Type DEVICE

Phonak Audéo L2M with Sound Processing Principle 3

Compensation of a hearing loss with Sound Processing Principle 3.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult hearing impaired persons (minimum age: 18 years) with and without experience with) hearing aids
* Healthy outer ear (without previous surgical procedures)
* Ability to fill in a questionnaire conscientiously
* Informed Consent as documented by signature

Exclusion Criteria

* Contraindications to the medical device in this study, e.g. known hypersensitivity or allergy to the investigational product
* Limited mobility and not in the position to attend weekly appointments
* Limited ability to describe listening impressions/experiences and the use of the hearing aid
* Inability to produce a reliable hearing test result
* Massively limited dexterity
* Known psychological problems
* Known central hearing disorders
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sonova AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sonova AG

Stäfa, Canton of Zurich, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sonova2018_37

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.